We are leaders, innovators and entrepreneurs working together to redefine the way we make medicines.
Corporate Executive Team
Saurabh Saha, MD, PhD
Chief Executive Officer and Director
Tia Bush
Chief Quality Officer
David Chao, PhD
Chief Administrative Officer
David Grainger, PhD
Chief Innovation Officer
Josh Hamermesh, MBA
Senior Vice President, Business Development
Iqbal Hussain, LLB
General Counsel
Javad Shahidi, MD, MSc
Chief Medical Officer
Kristen Sheppard, Esq.
Senior Vice President, Investor Relations and Corporate Communications
Thomas Templeman, PhD
Chief Technology Officer
Gregory Weinhoff, MD, MBA
Chief Financial Officer
Antoine Yver, MD, MSc
Chairman of Development
Board of Directors
Francesco De Rubertis, PhD
Chairman of the Board, Centessa Pharmaceuticals
Co-Founder & Partner, Medicxi
Read Bio
Co-Founder & Partner, Medicxi
Arjun Goyal, MD, MPHIL, MBA
Co-Founder and Managing Director
Vida Ventures
Read Bio
Vida Ventures
Mary Lynne Hedley, PhD
Senior Fellow and Strategic Advisor
The Broad Institute of M.I.T. and Harvard
Read Bio
The Broad Institute of M.I.T. and Harvard
Mathias Hukkelhoven, PhD
Former Senior Vice President, Global Regulatory, Safety & Biometrics
Bristol Myers Squibb (BMS)
Read Bio
Bristol Myers Squibb (BMS)
Samarth Kulkarni, PhD
Chief Executive Officer
CRISPR Therapeutics
Read Bio
CRISPR Therapeutics
Saurabh Saha, MD, PhD
Chief Executive Officer and Director
Read Bio
Carol Stuckley, MBA
Brett Zbar, MD
Managing Director and Global Head of Life Sciences
General Atlantic
Read Bio
General Atlantic